Assessment of Immunological Biomarkers in the First Year after Heart Transplantation

Table 2

Data sets with imputed values of the different immunological parameters CD25, CD95, IL2, IFN, plasmacytoid and myeloid dendritic cells, IP10, and MIG at different time points during the first year after heart transplantation. Data are represented as mean ± standard deviations.

	1st quarter	2nd quarter	2nd half year	Adjusted value
CD25	33.6%  ±  21.0%	34.7%  ±  21.9%	33.4%  ±  20.6%	0.78
CD95	39.2%  ±  23.7%	46.3%  ±  26.9%	45.6%  ±  28.7%	0.22
IL-2	9.2%  ±  11.6%	16.2%  ±  13.8%	18.3%  ±  15.5%	<0.01
IFN	10.7%  ±  12.4%	17.9%  ±  12.8%	24.9%  ±  21.4%	<0.01
pDCs	18.8%  ±  12.2%	26.4%  ±  10.5%	31.0%  ±  11.9%	<0.01
mDCs	41.2%  ±  20.9%	49.7%  ±  15.0%	47.7%  ±  21.0%	0.06
pDC/mDC ratio	0.78  ±  1.17	0.71  ±  0.71	1.05  ±  1.22	0.24
IP10	42.1 pg/mL  ±  42.0 pg/mL	35.1 pg/mL  ±  25.5 pg/mL	45.5 pg/mL  ±  43.9 pg/mL	0.25
MIG	29.6 pg/mL  ±  38.3 pg/mL	23.7 pg/mL  ±  16.6 pg/mL	25.4 pg/mL  ±  13.6 pg/mL	0.40

CD25, alpha chain of the interleukin-2 receptor; CD95, Fas receptor; IFN, interferon g; IL2, interleukin-2; IP10, CXC chemokine ligand 10; mDCs, myeloid dendritic cells; MIG, CXC chemokine ligand 9; pDCs, plasmacytoid dendritic cells.